0.1114
price down icon0.09%   -0.0001
 
loading
Schlusskurs vom Vortag:
$0.1115
Offen:
$0.1127
24-Stunden-Volumen:
530.09K
Relative Volume:
0.42
Marktkapitalisierung:
$6.92M
Einnahmen:
$1.47M
Nettoeinkommen (Verlust:
$-97.61M
KGV:
-0.0748
EPS:
-1.49
Netto-Cashflow:
$-80.90M
1W Leistung:
+6.10%
1M Leistung:
-4.46%
6M Leistung:
-56.97%
1J Leistung:
-97.59%
1-Tages-Spanne:
Value
$0.1081
$0.115
1-Wochen-Bereich:
Value
$0.0955
$0.1246
52-Wochen-Spanne:
Value
$0.082
$4.71

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
Firmenname
Lyra Therapeutics Inc
Name
Telefon
617-373-4600
Name
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Name
Mitarbeiter
30
Name
Twitter
@LyraTx
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
LYRA's Discussions on Twitter

Vergleichen Sie LYRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LYRA
Lyra Therapeutics Inc
0.1114 6.92M 1.47M -97.61M -80.90M -1.49
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.54 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
608.10 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.41 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.71 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.50 26.40B 3.81B -644.79M -669.77M -6.24

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-07 Herabstufung BofA Securities Buy → Underperform
2024-05-07 Herabstufung H.C. Wainwright Buy → Neutral
2024-05-07 Herabstufung Jefferies Buy → Hold
2024-05-06 Herabstufung William Blair Outperform → Mkt Perform
2023-10-06 Fortgesetzt BTIG Research Buy
2023-08-31 Eingeleitet H.C. Wainwright Buy
2022-05-24 Eingeleitet Cantor Fitzgerald Overweight
2020-05-26 Eingeleitet BTIG Research Buy
2020-05-26 Eingeleitet BofA/Merrill Buy
2020-05-26 Eingeleitet Jefferies Buy
2020-05-26 Eingeleitet William Blair Outperform
Alle ansehen

Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten

pulisher
Apr 30, 2025

Lyra Therapeutics Inc (LYRA) expanding its growth trajectory ahead - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Financial Fitness Check: Examining B. Riley Financial Inc (RILY)’s Key Ratios - DWinneX

Apr 30, 2025
pulisher
Apr 29, 2025

Rhinitis Pipeline 2025: Groundbreaking Clinical Advancements - openPR.com

Apr 29, 2025
pulisher
Apr 29, 2025

Keeping an Eye on Lyra Therapeutics Inc (LYRA) After Insider Trading Activity - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Lyra Therapeutics Inc (LYRA) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

What was Lyra Therapeutics Inc (LYRA)’s performance in the last session? - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Recent Insider Activity Could Benefit Schrodinger Inc (SDGR) - knoxdaily.com

Apr 29, 2025
pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 27, 2025

Lyra Therapeutics (LYRA) Expected to Announce Quarterly Earnings on Tuesday - American Banking and Market News

Apr 27, 2025
pulisher
Apr 25, 2025

iCoreConnect Inc [ICCT] Shares Fall Approximately -87.86% Over the Year - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Lyra Therapeutics Inc [LYRA] Shares Rise 7.02 % on Thursday - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

QBTS Stock Sees Surge of Approximately 14.13% in Last Five Days - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Deckers Outdoor Corp [DECK] Records 200-Day SMA of $160.33 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Shopify Inc [SHOP] Records 50-Day SMA of $99.94 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Analysts Say Lyra Therapeutics Inc (NASDAQ:LYRA) Can Really Get To 0.5 In 12 Months - Marketing Sentinel

Apr 24, 2025
pulisher
Apr 22, 2025

An Analysis of Lyra Therapeutics Inc (LYRA)’s Potential Price Growth - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Take off with Lyra Therapeutics Inc (LYRA): Get ready for trading - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

Is Lyra Therapeutics Inc (LYRA) worth investing in despite its undervalued state? - uspostnews.com

Apr 21, 2025
pulisher
Apr 11, 2025

Brokerages Set Lyra Therapeutics, Inc. (NASDAQ:LYRA) Target Price at $1.25 - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

Lyra Therapeutics stock hits 52-week low at $0.1 By Investing.com - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

Lyra Therapeutics stock hits 52-week low at $0.1 - Investing.com

Apr 08, 2025
pulisher
Apr 03, 2025

TCBI Stock Sees Decline of Approximately -2.19% in Last Five Days - knoxdaily.com

Apr 03, 2025
pulisher
Apr 01, 2025

Mateon Therapeutics (OTCMKTS:MATN) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 31, 2025
pulisher
Mar 28, 2025

Lyra Therapeutics stock hits 52-week low at $0.14 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Lyra Therapeutics stock hits 52-week low at $0.14 amid sharp decline - Investing.com Australia

Mar 28, 2025
pulisher
Mar 27, 2025

PTCT Stock Sees Decline of Approximately -2.93% in Last Five Days - knoxdaily.com

Mar 27, 2025
pulisher
Mar 26, 2025

Lyra Therapeutics Inc (LYRA) deserves deeper analysis - uspostnews.com

Mar 26, 2025
pulisher
Mar 21, 2025

A Closer Look at Lyra Therapeutics Inc (LYRA) Stock Gains - investchronicle.com

Mar 21, 2025
pulisher
Mar 19, 2025

Lyra Therapeutics stock plunges to 52-week low of $0.16 By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Lyra Therapeutics stock plunges to 52-week low of $0.16 - Investing.com India

Mar 18, 2025
pulisher
Mar 17, 2025

Analysts Set Lyra Therapeutics, Inc. (NASDAQ:LYRA) Target Price at $4.50 - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Analysts Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $9.33 - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Lyra Therapeutics (NASDAQ:LYRA) Earns “Neutral” Rating from HC Wainwright - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Lyra Therapeutics Reports 2024 Financial Results and Updates - TipRanks

Mar 15, 2025
pulisher
Mar 13, 2025

Arbor Realty Trust Closes a $1.15 Billion Repurchase Facility to Unwind Two Outstanding Collateralized Loan Obligations - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

FDA Green Light: Lyra's Nasal Polyp Treatment Advances as 52-Week Data Shows Promise - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

Lyra Therapeutics reports Q4 EPS ($1.43), consensus (13c) - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Lyra Therapeutics (LYRA) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 11, 2025

Zevra Therapeutics (ZVRA) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 06, 2025

Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions - Bain Capital

Mar 06, 2025
pulisher
Mar 03, 2025

Chronic Rhinosinusitis Pipeline 2024: FDA Updates, Therapy - openPR.com

Mar 03, 2025

Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.51
price down icon 0.01%
$21.58
price up icon 2.96%
$32.56
price up icon 0.06%
$29.24
price up icon 18.78%
$105.61
price up icon 3.06%
biotechnology ONC
$256.40
price up icon 0.63%
Kapitalisierung:     |  Volumen (24h):